Related Experiment Video
Updated: Sep 17, 2025

A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
One condition, different environments? Haematologic parameter dynamics and pulmonary embolism in urban vs. rural
Małgorzata Neścior-Piech1, Piotr Piech2,3, Zuzanna Szostak2
1First Department of Anaesthesiology and Intensive Therapy, Medical University, Lublin, Poland.
Introduction And Objective:
Pulmonary embolism (PE) remains a major cause of morbidity and mortality among orthopaedic patients. Despite documented cardiovascular disparities between urban and rural populations, data linking these environments with PE incidence and haematologic changes are scarce. The study investigates the differences in acute pulmonary embolism (APE) incidence and dynamic haematologic changes between urban and rural orthopaedic patients.
Material And Methods:
A retrospective analysis included 276 orthopaedic patients hospitalized over eight years in a tertiary centre in Eastern Poland. Patients were categorized by residence (urban vs. rural). Complete blood count parameters, notably red cell distribution width (RDW), platelet indices, and erythrocyte parameters, were analyzed on admission and at clinical suspicion of APE. APE was confirmed by computed tomography pulmonary angiography. Ethical approval was obtained (KE-0254/17/2019). Standard statistical tests were used (p<0.05).
Results:
APE incidence did not differ significantly between urban (39.1%) and rural (47.4%) patients (p=0.181). However, urban patients had significantly higher RDW values on admission (p=0.037). Additionally, females showed significantly elevated RDW, particularly in rural settings (p=0.038). Other haematologic parameters showed no significant differences between groups.
Conclusions:
Although residence did not significantly influence APE incidence, the elevated RDW in urban patients suggests environmental or lifestyle-related haematologic modulation. Considering the limited similar studies in the literature, RDW emerges as a potential, cost-effective biomarker for early APE risk stratification in orthopaedic patients.
More Related Videos
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction
Pulmonary Embolism III: Nursing Management
Venous Thrombosis IV: Nursing Management

